FI92824B - Förfarande för framställning av terapeutiskt användbara kromanderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara kromanderivat Download PDF

Info

Publication number
FI92824B
FI92824B FI892948A FI892948A FI92824B FI 92824 B FI92824 B FI 92824B FI 892948 A FI892948 A FI 892948A FI 892948 A FI892948 A FI 892948A FI 92824 B FI92824 B FI 92824B
Authority
FI
Finland
Prior art keywords
formula
compound
preparation
color
acid
Prior art date
Application number
FI892948A
Other languages
English (en)
Finnish (fi)
Other versions
FI92824C (sv
FI892948A0 (sv
FI892948A (sv
Inventor
Guenther Haeusler
Rolf Gericke
Hanns Wurziger
Manfred Baumgarth
Ingeborg Lues
Rolf Bergmann
Peyer Jacques De
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3820506A external-priority patent/DE3820506A1/de
Priority claimed from DE3835011A external-priority patent/DE3835011A1/de
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of FI892948A0 publication Critical patent/FI892948A0/sv
Publication of FI892948A publication Critical patent/FI892948A/sv
Application granted granted Critical
Publication of FI92824B publication Critical patent/FI92824B/sv
Publication of FI92824C publication Critical patent/FI92824C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
FI892948A 1988-06-16 1989-06-15 Förfarande för framställning av terapeutiskt användbara kromanderivat FI92824C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3820506 1988-06-16
DE3820506A DE3820506A1 (de) 1988-06-16 1988-06-16 -n-heterocyclisch substituierte chromanderivate und ihre verwendung als arzneimittel
DE3835011A DE3835011A1 (de) 1988-10-14 1988-10-14 Chromanderivate
DE3835011 1988-10-14

Publications (4)

Publication Number Publication Date
FI892948A0 FI892948A0 (sv) 1989-06-15
FI892948A FI892948A (sv) 1989-12-17
FI92824B true FI92824B (sv) 1994-09-30
FI92824C FI92824C (sv) 1995-01-10

Family

ID=25869185

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892948A FI92824C (sv) 1988-06-16 1989-06-15 Förfarande för framställning av terapeutiskt användbara kromanderivat

Country Status (11)

Country Link
EP (1) EP0346724A1 (sv)
JP (1) JPH0240375A (sv)
KR (1) KR910000711A (sv)
AU (1) AU626549B2 (sv)
DK (1) DK296789A (sv)
FI (1) FI92824C (sv)
HU (1) HUT56096A (sv)
IL (1) IL90613A0 (sv)
NO (1) NO174391C (sv)
NZ (1) NZ229540A (sv)
PT (1) PT90864B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
FR2621587B1 (fr) * 1987-10-12 1990-02-09 Sanofi Sa Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
GB8924376D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
EP0430621A3 (en) * 1989-11-29 1992-03-04 Beecham Group P.L.C. Process for the preparation of chiral 3,4-epoxy benzopyrans
JP2575226B2 (ja) * 1990-05-11 1997-01-22 吉富製薬株式会社 光学活性な３，４−ジヒドロ−３，４−エポキシ−２ｈ−１ベンゾピラン化合物の製造法およびその合成中間体
CA2070243A1 (en) * 1991-06-14 1992-12-15 Akira Shiozawa Chroman derivatives
WO1994012493A1 (en) * 1992-11-25 1994-06-09 Sandoz, Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals
SK88994A3 (en) * 1992-11-25 1995-06-07 Sandoz Ag 2,2-dialkyl-2h-1-benzopyrans and 2,2-dialkyl-3,4-dihydro- -3-hydroxy-2h-1-benzopyrans
IL108841A0 (en) * 1993-03-10 1994-06-24 Pfizer Res & Dev Benzopyrans
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
JP2007000772A (ja) * 2005-06-23 2007-01-11 Casio Electronics Co Ltd 二重マイクロカプセル、その製造方法及びマイクロカプセルの表面処理方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
DE3364734D1 (en) * 1982-10-19 1986-08-28 Beecham Group Plc Novel chromans and chromenes
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
CH674984A5 (sv) * 1987-05-16 1990-08-15 Sandoz Ag
FR2621587B1 (fr) * 1987-10-12 1990-02-09 Sanofi Sa Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives

Also Published As

Publication number Publication date
NZ229540A (en) 1991-03-26
NO174391B (no) 1994-01-17
FI92824C (sv) 1995-01-10
FI892948A0 (sv) 1989-06-15
HUT56096A (en) 1991-07-29
AU626549B2 (en) 1992-08-06
EP0346724A1 (de) 1989-12-20
JPH0240375A (ja) 1990-02-09
FI892948A (sv) 1989-12-17
AU3644089A (en) 1989-12-21
NO174391C (no) 1994-04-27
NO892494L (no) 1989-12-18
KR910000711A (ko) 1991-01-30
NO892494D0 (no) 1989-06-15
IL90613A0 (en) 1990-01-18
PT90864B (pt) 1994-11-30
PT90864A (pt) 1989-12-29
DK296789A (da) 1989-12-17
DK296789D0 (da) 1989-06-15

Similar Documents

Publication Publication Date Title
FI92824B (sv) Förfarande för framställning av terapeutiskt användbara kromanderivat
US5240941A (en) Thioxo quinoline compounds, composition and method of use
FI93358B (sv) Förfarande för framställning av terapeutiskt användbara kromanderivat
CA1340960C (en) Chroman derivatives
US5387587A (en) Chroman derivatives
US4251537A (en) Hypotensive 3,4-dihydro-2,2-dimethyl-4-amino-2H-benzo[b]pyran-3-ols
IE843103L (en) Benzofurans and pyrans
FI92825B (sv) Förfarande för framställning av terapeutiskt användbara kromanderivat
FI95700B (sv) Förfarande för framställning av terapeutiskt användbara kromanderivat
US5112972A (en) Synthesis of chroman derivatives
US5112839A (en) Chroman derivatives
US6071953A (en) Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
AU645373B2 (en) Chroman derivatives
NO176517B (no) Analogifremgangsmåte for fremstilling av antihypertensive og anti-arytmiske 4-(2-imino-1,2-dihydro-1-pyridyl(pyrimidinyl))-kromanderivater
SU1124886A3 (ru) Способ получени хинолонов
US5036068A (en) 4-(pyridyl)- and 4-(oxo-pyridyl)-1,3-benzoxazines
JP3468589B2 (ja) ５−アミノフラボン誘導体

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUN